Another explanation is that several cancer cell types have higher levels of antioxidants, which could inhibit ROS toxicity; specifically, increased levels of superoxide dismutase (SOD-2) and thioredoxin reductase 2 (TRX-2) were observed in mitochondria from cancer tissue samples (70–72). This evidence concerns the gene TXNRD2 and cancer.